about
AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in miceThe alternative complement pathway regulates pathological angiogenesis in the retinaAdeno-associated virus mediated delivery of a non-membrane targeted human soluble CD59 attenuates some aspects of diabetic retinopathy in mice.Activated complement classical pathway in a murine model of oxygen-induced retinopathy.Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.Next-generation sequencing analysis of gene regulation in the rat model of retinopathy of prematurity.Inhibition of the alternative complement pathway preserves photoreceptors after retinal injury.Loss of Complement Factor H in Plasma Increases Endothelial Cell MigrationRabdosia japonica var. glaucocalyx Flavonoids Fraction Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice.Diabetes-related changes in the protein composition and the biomechanical properties of human retinal vascular basement membranes.Complement component C3aR constitutes a novel regulator for chick eye morphogenesis.The Complement System Is Critical in Maintaining Retinal Integrity during Aging.Complement-Mediated Activation of the NLRP3 Inflammasome and Its Inhibition by AAV-Mediated Delivery of CD59 in a Model of Uveitis.The complement system in glioblastoma multiformeNew insight into the role of the complement in the most common types of retinopathy-current literature review
P2860
Q31154707-DE25590A-E908-4A91-BC2C-B38DFDC34714Q33775122-A0809055-41BE-41A4-9D85-FE3C0B418046Q35027989-771B72C3-22FC-494E-B8BC-379231621900Q35075338-BF1590E2-1C88-4FBD-81B4-D88E623358BAQ36446437-A294C306-6D86-4E79-AD22-50AD70E940FFQ38488946-E8598B02-8C1C-4C5F-AC39-C14546A2684CQ38803123-2CB42D91-9D69-4CE8-BCF6-0EC05312D3B4Q41440969-B78F3EAF-8F47-4372-BB71-97F6B447E852Q41465226-54DD4BA8-CC1C-45B4-9D93-F04E070EB2B5Q47239210-391B58FB-12D7-4D76-AAB9-8F8EA1C4D6F3Q50435789-104F106F-8D11-4F30-96FC-B77F9199205CQ51766201-BA2A03A9-6D43-4515-BD6E-937643CA0198Q52313908-AF80FCA7-342E-40F4-BB73-BA9D7F9867D5Q58748412-62E5A3BA-3F64-484E-837B-BF26A51178ACQ59137366-EC02170D-7537-47E6-8929-0B636D8E04BF
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Complement involvement in neovascular ocular diseases.
@ast
Complement involvement in neovascular ocular diseases.
@en
Complement involvement in neovascular ocular diseases.
@nl
type
label
Complement involvement in neovascular ocular diseases.
@ast
Complement involvement in neovascular ocular diseases.
@en
Complement involvement in neovascular ocular diseases.
@nl
prefLabel
Complement involvement in neovascular ocular diseases.
@ast
Complement involvement in neovascular ocular diseases.
@en
Complement involvement in neovascular ocular diseases.
@nl
P1476
Complement involvement in neovascular ocular diseases
@en
P2093
Aristomenis Thanos
Ryoji Yanai
P304
P356
10.1007/978-1-4614-0106-3_10
P407
P577
2012-01-01T00:00:00Z